Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Tofacitinib in Chronic Plaque Psoriasis
NCT07261306Phase 1Recruiting
- Sponsor
- Lahore General Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in psoriasis comparing Group mTX with Tofacitinib (2 arms). Primary endpoint: Efficacy Achievement at 12 weeks. Started Aug 2025; status: recruiting.
02
Drugs
methotrexatetofacitinib
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07261306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261306.